Objective: To describe an oncological population affected with severe febrile neutropenia, its demographic, nutritional, and microbiological features, their treatment and severity of '/> Severe febrile neutropenia in children with cancer: A descriptive study at the Hospital Universitario de Santander
首页> 外文期刊>Universidad Industrial de Santander. Revista. Salud >Severe febrile neutropenia in children with cancer: A descriptive study at the Hospital Universitario de Santander
【24h】

Severe febrile neutropenia in children with cancer: A descriptive study at the Hospital Universitario de Santander

机译:癌症患儿严重发热性中性粒细胞减少症:桑坦德大学医院的一项描述性研究

获取原文
       

摘要

align="justify">Objective: To describe an oncological population affected with severe febrile neutropenia, its demographic, nutritional, and microbiological features, their treatment and severity of the illness. Materials and methods: A descriptive-prospective clinical chart review from attended patients at the Hospital Universitario de Santander, from January/2007 to January/2008. Results: Twenty (21) patients contributed with 35 febrile neutropenia episodes; 65.7% were male; they aged average was 5.6-years; 38.37% lived in Bucaramanga Metropolitan Area; 91.4% had low economic status. The most frequent oncological diagnosis was acute lumphocytic leukemia. No one presented abdominal pain or neurological symptoms. The neutropenia was detected 8.5 days after the last chemotherapy cycle. 31.4% patients had no absolute neutrophils; 54.2% blood platelets 50,000/mm3, 45.7% had reactive C protein 90 mg|/dL. The bloodculture was positive only in 7 patients. It was found the infection focus in 88.6% of the episodes and the most frequently diagnosis were related with the gastrointestinal tract. The most used empiric antibiotic regimen was oxacilin+amikacin (71.4%), but were necessary change it in 40%. The lethality was of 4.8%. In average, 1.48 beds/day were occupied to treat this pathology. Conclusions: The patients with febrile neutropenia present multiple factors that could indicate us bacterial infection. Further investigations must continue to establish these factors and the bacterial flora of each institution. Many patients needed antibiotic change; that is the reason to define a new empiric treatment. Salud UIS 2010; 42: 103-111.
机译:align =“ justify”> 目的:描述患有严重发热性中性粒细胞减少症的肿瘤人群,其人口统计学,营养学和微生物学特征,其治疗方法和疾病严重程度。 材料和方法:从2007年1月至2008年1月在桑坦德大学医院就诊患者的描述性前瞻性临床图表审查。 结果:二十(21)例患者有35例发热性中性粒细胞减少症发作;男性为65.7%;他们的平均年龄为5.6岁; 38.37%居住在布卡拉曼加都会区; 91.4%的人经济地位低下。肿瘤学诊断最频繁的是急性淋巴细胞白血病。没有人出现腹痛或神经系统症状。在最后一个化疗周期后8.5天检测到中性粒细胞减少。 31.4%的患者没有绝对中性粒细胞;血小板<50,000 / mm3的血小板占54.2%,反应性C蛋白<90 mg | / dL占45.7%。血培养阳性仅7例。发现感染集中在88.6%的发作中,最常见的诊断与胃肠道有关。最常用的经验性抗生素治疗方案是奥沙西林+阿米卡星(71.4%),但有必要将其改为40%。致死率是4.8%。平均每天有1.48张病床被用于治疗该病状。 结论:高热性中性粒细胞减少症患者表现出多种因素,可能表明我们感染了细菌。必须继续进行调查以建立这些因素以及每个机构的细菌菌群。许多患者需要更换抗生素。这就是定义新的经验处理的原因。 Salud UIS 2010; 42:103-111

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号